Discovery channel feed

Turn­ing the ta­ble on CD47, Penn team primes macrophages to ig­nore 'don't eat me' sig­nal

7 years ago

NIH re­searchers re­port an­i­mal mod­el val­i­da­tion for stem cell-based ap­proach to ad­vanced dry AMD

7 years ago

Block­ing PD-L1 pro­duc­tion in mice, UCSF team spot­lights pre­clin­i­cal promise of a Pfiz­er-backed I/O drug

7 years ago

Park­er-backed can­cer sci­en­tists shine a light on an emerg­ing path­way in pan­cre­at­ic can­cer

7 years ago

Ear­ly re­search sug­gests ex­ist­ing drugs could stran­gle build­ing blocks of metas­ta­sis

7 years ago

An­ti-ag­ing start­up Ele­vian en­lists In­sil­i­co on AI quest for 'y­oung blood'

7 years ago
AI

Com­pu­ta­tion­al sci­en­tists de­sign a new IL-2 can­cer drug and spin it out in­to a biotech start­up

7 years ago
Startups

Gilead stuffs an­oth­er NASH drug dis­cov­ery pro­gram in­to a grow­ing port­fo­lio

7 years ago

Tar­get­ing CD47? UCLA joins band­wag­on, with gel to stem tu­mors from resur­fac­ing

7 years ago

As­traZeneca, Can­cer Re­search UK set up ge­nomics hub to fight up­hill bat­tle against can­cer

7 years ago
R&D

Un­de­terred by ex­ec ex­o­dus, Im­muno­core nabs $100M cash to co-de­vel­op pre­clin­i­cal as­set with Roche

7 years ago
R&D

Sanofi teams with non-prof­it on a land­mark new drug for sleep­ing sick­ness

7 years ago
R&D
Pharma

Deer­field bankrolls an $80M re­search cen­ter at Dana-Far­ber de­vot­ed to pro­tein degra­da­tion

7 years ago

Bil­lion­aire gifts Har­vard a his­toric $200M to 'ex­pe­dite' trans­la­tion­al bio­med­ical re­search work

7 years ago
People

Dana-Far­ber team iden­ti­fies new 'gene traf­fic con­trol' tar­gets in two rare, ag­gres­sive can­cers

7 years ago

Gilead throws its weight — and $50M cash — be­hind Tan­go's I/O dis­cov­ery en­gine

7 years ago

As CRISPR emerges, re­searchers spot­light pos­i­tive ef­fects in pre­na­tal gene edit­ing treat­ment for mice

7 years ago

Spark's CSO is wrap­ping up an­i­mal stud­ies on a gene ther­a­py for Pompe dis­ease as new work in the field sees ex­plo­sive growth

7 years ago
Cell/Gene Tx

An au­toim­mune up­start turns PD-L1 around to blaze a new ap­proach to di­a­betes, mul­ti­ple scle­ro­sis

7 years ago
Startups

Park­er col­lab­o­ra­tor Tes­sa al­lies with St. Jude, launch­es a new T cell pro­gram for pe­di­atric brain can­cer

7 years ago
R&D

Mayo team spot­lights the role of senes­cent cells in neu­rode­gen­er­a­tion, start­ing down a path­way that may lead to Alzheimer’s

7 years ago

GSK-backed sci­en­tif­ic team at UCSF says they found the im­mor­tal­i­ty switch in can­cer cells — and know how to turn it off

7 years ago

Ele­vian banks $5.5 mil­lion seed round to pur­sue 'y­oung blood' de­rived an­ti-ag­ing tech

7 years ago

Atara brings an­oth­er ex­pe­ri­enced in­ves­ti­ga­tor on­to its off-the-shelf CAR-T quest in lat­est col­lab­o­ra­tion

7 years ago
R&D
First page Previous page 67891011 Next page Last page
A service from the Financial Times